Preoperative BRAF(V600E) mutation detection in thyroid carcinoma by immunocytochemistry

The BRAF(V600E) (BRAF) mutation is present in 40–50% of papillary thyroid carcinomas (PTC) and has been associated with more aggressive clinicopathological characteristics of PTC. The aim of this study was to evaluate different methods for preoperative identification of the BRAF mutation in PTC usin...

Descripción completa

Detalles Bibliográficos
Autores principales: Swan, Kristine Zøylner, Madsen, Stine Horskær, Bonnema, Steen Joop, Nielsen, Viveque Egsgaard, Jespersen, Marie Louise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804421/
https://www.ncbi.nlm.nih.gov/pubmed/35951496
http://dx.doi.org/10.1111/apm.13267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804421/
https://www.ncbi.nlm.nih.gov/pubmed/35951496
http://dx.doi.org/10.1111/apm.13267

Ejemplares similares